Sonova Holding (OTCMKTS:SONVY) Given Consensus Recommendation of "Moderate Buy" by Analysts

Key Points

• Sonova (OTCMKTS:SONVY) has a consensus analyst recommendation of "Moderate Buy" from eight covering firms, made up of 1 sell, 4 hold, 1 buy and 2 strong buy ratings.
• Recent analyst actions vary: Jefferies downgraded Sonova to a "moderate sell," BNP Paribas Exane upgraded it to "strong-buy," and Zacks Research moved its rating from "strong sell" to "hold."
• Shares opened at $46.85, with a 50‑day/200‑day simple moving average of $48.67/$51.56, a 12‑month range of $42.26–$68.76, current ratio 1.24, quick ratio 0.91 and debt‑to‑equity of 0.51.

Sonova Holding (OTCMKTS:SONVY - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight research firms that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company.

Several brokerages recently issued reports on SONVY. Jefferies Financial Group downgraded shares of Sonova from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, March 18th. BNP Paribas Exane upgraded shares of Sonova from a "strong sell" rating to a "strong-buy" rating in a research report on Tuesday, March 10th. Finally, Zacks Research upgraded shares of Sonova from a "strong sell" rating to a "hold" rating in a research report on Monday, February 9th.

Sonova Stock Performance

Shares of OTCMKTS SONVY opened at $46.85 on Tuesday. The firm's 50-day simple moving average is $48.67 and its 200 day simple moving average is $51.56. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. Sonova has a 12-month low of $42.26 and a 12-month high of $68.76.

Sonova Company Profile

Sonova AG OTCMKTS: SONVY is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.